Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
about
Chemotherapy-induced peripheral neurotoxicity: a critical analysisManagement of multiple myeloma with bortezomib: experts review the data and debate the issues.Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.Central neurotoxicity of immunomodulatory drugs in multiple myeloma.High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitisInternational Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.Thalidomide in multiple myeloma: past, present and future.Maintenance therapy for multiple myeloma with particular emphasis on thalidomide.New therapies in multiple myeloma.Treatment of relapsed and refractory myeloma.Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trialGuidelines for the diagnosis and management of multiple myeloma 2011.New Treatment Approaches for Older Adults with Multiple Myeloma.Management of double-refractory multiple myeloma.Therapy-related peripheral neuropathy in multiple myeloma patients.The double-edged sword: Neurotoxicity of chemotherapy.Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.Chemotherapy-Related Neurotoxicity.Pomalidomide in the treatment of relapsed multiple myeloma.Prevalence of peripheral neuropathy in multiple myeloma at initial diagnosis.Falls in older adults with multiple myeloma.Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 studyLong-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
P2860
Q27010318-0D70C644-DD7B-4367-955C-F17D098B5CA3Q31098282-D1DACC58-7E09-4CB3-93DA-5E38EB148425Q33632270-BBC4F6F0-DF95-4ECE-84E1-BE16CE10C33EQ33703096-06297F65-BCEA-4E24-B60B-B30B52D3670AQ35228770-FB0F6059-9EB5-4C07-A720-A8111754B396Q35746349-23BFC674-20DE-49C2-8452-5676C64D812FQ35802414-40B01E9F-FFD0-44B6-8E77-E98A8874A1A4Q36616493-6503B94A-3233-4AC3-BDD0-006F4E497CCBQ36698947-344BCF6A-A7C0-4AFA-9EA7-9457F0E8DB86Q36986576-5613428B-D39D-4101-A784-8CAE378EC50DQ37209929-3D17A3BE-461D-402F-9317-2FC3BDD86DF2Q37288200-EDC6E386-1314-4F30-8FED-0DDB62E70626Q37875193-F8008F7B-0508-4378-97EA-0F9AAB98FA29Q38048281-AF823234-82B7-46B0-81E6-CEC2A3A1CC01Q38131456-52668881-2324-4B70-A4D4-7075E719848AQ38268525-C32BA368-8CBD-4688-9821-09CC8BF29795Q38274890-2E7D328E-5644-4059-8C88-F88C5B9ED2E4Q38738098-E36D3C01-013F-4BEE-90EB-8EA8A2D7C1CFQ38904676-B956CFCA-3FFD-49E3-8E94-A25BD98EC4F9Q39388200-3CF4BA4E-E0AC-4FC0-A778-862728B21506Q43433029-40F6D6D4-9DF3-4813-B9D3-AF551AC62B4EQ47313009-B3417847-2D77-4C4D-9100-FE3C76F19526Q56971945-2251A2D4-17A2-4A73-BD75-E09A39DA4613Q56982314-966813F2-60D8-4D2B-A35C-B5E9A1567CD5
P2860
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Neurological toxicity of long- ...... atients with multiple myeloma.
@en
Neurological toxicity of long-term
@nl
type
label
Neurological toxicity of long- ...... atients with multiple myeloma.
@en
Neurological toxicity of long-term
@nl
prefLabel
Neurological toxicity of long- ...... atients with multiple myeloma.
@en
Neurological toxicity of long-term
@nl
P2093
P2860
P50
P1476
Neurological toxicity of long- ...... atients with multiple myeloma.
@en
P2093
Claudia Cellini
Delia Cangini
Elena Zamagni
Francesca Pastorelli
Paola Tacchetti
Patrizia Tosi
Rosaria Plasmati
Sante Tura
P2860
P304
P356
10.1111/J.1600-0609.2004.00382.X
P577
2005-03-01T00:00:00Z